ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of supplementation with ProAlgaZyme (a
novel fermentation product of a freshwater algae ecosystem) vs. placebo on Metabolic Syndrome
and indicators of cardiovascular health including: body weight and fat, blood lipids,
inflammatory markers such as hsCRP, blood pressure and fasting blood glucose.